FOR IMMEDIATE RELEASE
(BRUSSELS, BELGIUM, 06 March 2012) – ISPE announced today its first European conference of the year, focused on the global evolution of aseptic processing in the pharmaceutical industry. This two-day event, with a strong focus on European concerns, will address the challenges companies face in producing sterile pharmaceutical products. It will take place in Frankfurt, Germany on 26 – 27 March.
Attendees will learn from leading manufacturing experts about barrier isolation, vaccine manufacturing and technology innovations related to aseptic processing. Each track will draw heavily from the recently released, FDA-reviewed ISPE Baseline® Guide: Sterile Product Manufacturing Facilities (Second Edition), the industry’s go-to guide for aseptic processing. Attendees will receive a complimentary copy of the Guide, a €385 value.
“As the technical voice of manufacturing and engineering in the pharmaceutical industry, ISPE is committed to presenting programmes that facilitate relevant dialogue and the sharing of best practices among industry leaders, manufacturing experts and leading regulators,” said Nancy Berg, ISPE’s new President and CEO. “At a time when manufacturing operations are under tremendous pressure to improve effectiveness, deliver quality and reduce costs, ISPE is responding with new programmes featuring dynamic content.”
Titled “Global Evolution of Aseptic Processing: Implementing Risk-Based Manufacturing Solutions,” the conference will feature four keynote presentations from recognized industry experts. The conference will contain three distinct tracks.
For more information, including detailed agendas and registration information, visit www.ISPE.org/2012AsepticEUConference.
Additionally, a related training course will be offered in conjunction with this event. The course, titled “Facility Project Management in the Regulated Pharmaceutical Industry,” will be presented on 28- 29 March. Detailed information can be found at www.ISPE.org/2012-Frankfurt-Training.
ISPE, the International Society for Pharmaceutical Engineering, is a not-for-profit Society of 22,000 pharmaceutical professionals in 90 countries who use expert knowledge to create high-quality, cost-effective GMP solutions. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.